Castleark Management’s AtriCure ATRC Stock Holding History

Castleark Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-87,881	Closed	-$3.59M	–	290
2022 Q2	$3.59M	Sell	87,881 -41,745	-32%	-$1.98M	0.19%	119
2022 Q1	$8.51M	Sell	129,626 -2,710	-2%	-$176K	0.37%	60
2021 Q4	$9.2M	Sell	132,336 -13,630	-9%	-$991K	0.34%	76
2021 Q3	$10.2M	Buy	145,966 +32,165	+28%	+$2.48M	0.39%	69
2021 Q2	$9.03M	Buy	+113,801	New	+$8.27M	0.3%	92
2016 Q1	–	Sell	-321,215	Closed	-$7.21M	–	370
2015 Q4	$7.21M	Sell	321,215 -31,095	-9%	-$641K	0.22%	119
2015 Q3	$7.72M	Buy	+352,310	New	+$8.8M	0.25%	107
2014 Q4	–	Sell	-568,222	Closed	-$10.7M	–	342
2014 Q3	$10.7M	Sell	568,222 -39,932	-7%	-$636K	0.3%	56
2014 Q2	$11.2M	Buy	608,154 +39,932	+7%	+$665K	0.31%	58
2014 Q1	$10.7M	Buy	568,222 +229,686	+68%	+$4.71M	0.3%	56
2013 Q4	$6.32M	Buy	+338,536	New	+$4.92M	0.18%	108

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Castleark Management's ATRC Position: Q3 2022 in Review

Castleark Management sold out of AtriCure (ATRC) in Q3 2022, closing a stake of 87,881 shares — an estimated $3.59M sold.

Castleark Management first reported a position in ATRC in Q4 2013 and held it in 11 quarters. The position peaked at $11.2M in Q2 2014. 214 funds tracked by Wall St. Rank hold ATRC as of Q3 2022.

Castleark Management reported no remaining AtriCure position as of Q3 2022 after selling out during the quarter.
Castleark Management sold 87,881 AtriCure shares in Q3 2022, an estimated $3.59M.
Castleark Management first reported a position in AtriCure in Q4 2013 and held it in 11 quarters.
Castleark Management's AtriCure position peaked at $11.2M in Q2 2014.
214 funds tracked by Wall St. Rank held AtriCure as of Q3 2022.

Based on Castleark Management's 13F filing for Q3 2022, filed 15 Nov 2022.